STOCK WATCH

SHARES in Hvivo plunged even after receiving backing from fund manager Neil Woodford.

The veteran investor increased his holding to 22.5pc from 20pc after drip-feeding cash in over the past few days.

But others seem less confident in the firm’s prospects – IP Group has reduced its holding to 17.1pc from 20.7pc. Hvivo is a drug discovery company researching vaccines for conditions such as Asthma.

Shares dropped 4.9pc, or 2.5p, to 48.5p.